Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same
AssigneeSuperGen, Inc.
InventorsDavid J. Bearss, Rajashree Joshi-Hangal, Xiao-Hui Liu, Pasit Phiasivongsa, Sanjeev G. Redkar, Hariprasad Vankayalapati
Life of this patent
Estimating the term…
Abstract
The present invention relates to pharmaceutical formulations comprising the protein kinase inhibitor, MP470, and methods of using same in treating conditions involving undesirable cell proliferation, such as cancer.
Claims34
A pharmaceutical formulation for oral administration comprising a salt of MP470 of structure formula (I).
A pharmaceutical formulation for oral administration comprising a salt form of MP470 of structure formula (I), wherein the salt form of MP470 in the formulation has a decreased toxicity and an increased oral bioavailability relative to the free base form of MP470.
Dependencies are inferred from the claim text.